Five-year follow-up sustained remission with rituximab in a patient with focal segmental glomerulosclerosis: A case report
This case contributes to the growing evidence supporting rituximab's therapeutic potential in adult FSGS, while highlighting the need for randomized controlled trials to establish its efficacy and optimal use in this challenging patient population.
Authors
- Paulo Novis Rocha
- José Andrade Moura
- José A. Moura-Neto
- Ana Flavia Moura
- Daniela Moura-Landim
Institutions
- Universidade Federal da Bahia (BR)
- Escola Bahiana de Medicina e Saúde Pública (BR)
- Fundação Bahiana de Infectologia (BR)
- Hypertension Institute (US)
Publication Details
- Journal
- World Journal of Nephrology
- Published
- 2026-03-13
- DOI
- https://doi.org/10.5527/wjn.v15.i1.116620
- Primary Topic
- Renal Diseases and Glomerulopathies
- Type
- article
- Field-Weighted Citation Impact
- 0.00